InnoCare's TYK2 inhibitor shows potential to rival Sotyktu in Chinese phase 2 psoriasis trial

InnoCare's TYK2 inhibitor shows potential to rival Sotyktu in Chinese phase 2 psoriasis trial jwaldron Wed, 10/09/2024 - 08:31